The development of gemcitabine and carboplatin in the treatment of non-small-cell lung cancer

Lung Cancer

Volumn 50, Issue SUPPL. 1, 2005, Pages

  Cullen, M ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Carboplatin; Gemcitabine; Lung cancer; Non small cell lung cancer; Thoracic cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; IFOSFAMIDE; MITOMYCIN; PACLITAXEL; VINBLASTINE;

ALOPECIA; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; LUNG NON SMALL CELL CANCER; NEUROTOXICITY; PRIORITY JOURNAL; QUALITY OF LIFE; SENSORY DYSFUNCTION; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE II; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; HUMANS; LUNG NEOPLASMS;

EID: 27744481566     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(05)81550-8     Document Type: Article

References (7)

1. Abstract 1162 Sederhom C Gemcitabine (G) compared with gemcitabine plus carboplatin (GC) in advanced non-small cell lung cancer (NSCLC): a phase III study by the Swedish Lung Cancer Study Group (SLUSG) Am Soc Clin Oncol 2002
2. Rudd RM, Gower NH, and Spiro SG Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group J Clin Oncol 23 1 2005 142 153
3. Grigorescu AC, Draghici IN, Niotipir C, Gutulescu N, and Corlan E Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial Lung Cancer 37 1 2002 9 14
4. Abstract LBA7025 Treat J, Belani P, and Edelman MJ Randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): update of the Alpha oncology trial (A1-99002L) Am Soc Clin Oncol 2005
5. Abstract 7000 Kosmidis PA, Kalofonos C, and Syrigos K Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC) Am Soc Clin Oncol 2005
6. Zatloukal P, Petruzelka L, and Zemanova M Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial Lung Cancer 41 3 2003 321 331
7. Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, and Tanimoto M Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer J Clin Oncol 22 19 2004 3852 3859